Martin R. Turner
Martin R. Turner
Nuffield Department of Clinical Neurosciences, Oxford University
Verified email at - Homepage
Cited by
Cited by
Amyotrophic lateral sclerosis
MC Kiernan, S Vucic, BC Cheah, MR Turner, A Eisen, O Hardiman, ...
The lancet 377 (9769), 942-955, 2011
Evidence of widespread cerebral microglial activation in amyotrophic lateral sclerosis: an [11C](R)-PK11195 positron emission tomography study
MR Turner, A Cagnin, FE Turkheimer, CCJ Miller, CE Shaw, DJ Brooks, ...
Neurobiology of disease 15 (3), 601-609, 2004
Controversies and priorities in amyotrophic lateral sclerosis
MR Turner, O Hardiman, M Benatar, BR Brooks, A Chio, M De Carvalho, ...
The Lancet Neurology 12 (3), 310-322, 2013
Biomarkers in amyotrophic lateral sclerosis
MR Turner, MC Kiernan, PN Leigh, K Talbot
The Lancet Neurology 8 (1), 94-109, 2009
Corpus callosum involvement is a consistent feature of amyotrophic lateral sclerosis
N Filippini, G Douaud, CE Mackay, S Knight, K Talbot, MR Turner
Neurology 75 (18), 1645-1652, 2010
Variants of the elongator protein 3 ( ELP3 ) gene are associated with motor neuron degeneration
CL Simpson, R Lemmens, K Miskiewicz, WJ Broom, VK Hansen, ...
Human molecular genetics 18 (3), 472-481, 2009
Neurofilament light chain: a prognostic biomarker in amyotrophic lateral sclerosis
CH Lu, C Macdonald-Wallis, E Gray, N Pearce, A Petzold, N Norgren, ...
Neurology 84 (22), 2247-2257, 2015
Exome-wide rare variant analysis identifies TUBA4A mutations associated with familial ALS
BN Smith, N Ticozzi, C Fallini, AS Gkazi, S Topp, KP Kenna, EL Scotter, ...
Neuron 84 (2), 324-331, 2014
Amyotrophic lateral sclerosis-frontotemporal spectrum disorder (ALS-FTSD): Revised diagnostic criteria
MJ Strong, S Abrahams, LH Goldstein, S Woolley, P Mclaughlin, ...
Amyotrophic lateral sclerosis and frontotemporal degeneration 18 (3-4), 153-174, 2017
Integration of structural and functional magnetic resonance imaging in amyotrophic lateral sclerosis
G Douaud, N Filippini, S Knight, K Talbot, MR Turner
Brain 134 (12), 3470-3479, 2011
Amyotrophic lateral sclerosis in an urban setting
CA Johnston, BR Stanton, MR Turner, R Gray, AHM Blunt, D Butt, ...
Journal of neurology 253 (12), 1642-1643, 2006
A proposed staging system for amyotrophic lateral sclerosis
JC Roche, R Rojas-Garcia, KM Scott, W Scotton, CE Ellis, R Burman, ...
Brain 135 (3), 847-852, 2012
Diffusion imaging of whole, post-mortem human brains on a clinical MRI scanner
KL Miller, CJ Stagg, G Douaud, S Jbabdi, SM Smith, TEJ Behrens, ...
Neuroimage 57 (1), 167-181, 2011
Juvenile ALS with basophilic inclusions is a FUS proteinopathy with FUS mutations
D Bäumer, D Hilton, SML Paine, MR Turner, J Lowe, K Talbot, O Ansorge
Neurology 75 (7), 611-618, 2010
Inflammation and neurovascular changes in amyotrophic lateral sclerosis
MC Evans, Y Couch, N Sibson, MR Turner
Molecular and Cellular Neuroscience 53, 34-41, 2013
Mechanisms, models and biomarkers in amyotrophic lateral sclerosis
MR Turner, R Bowser, L Bruijn, L Dupuis, A Ludolph, M McGrath, ...
Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 14 (sup1), 19-32, 2013
Prolonged survival in motor neuron disease: a descriptive study of the King’s database 1990–2002
MR Turner, MJ Parton, CE Shaw, PN Leigh, A Al-Chalabi
Journal of Neurology, Neurosurgery & Psychiatry 74 (7), 995-997, 2003
Genome-wide analyses identify KIF5A as a novel ALS gene
A Nicolas, KP Kenna, AE Renton, N Ticozzi, F Faghri, R Chia, ...
Neuron 97 (6), 1268-1283. e6, 2018
Towards a neuroimaging biomarker for amyotrophic lateral sclerosis
MR Turner, J Grosskreutz, J Kassubek, S Abrahams, F Agosta, M Benatar, ...
The Lancet Neurology 10 (5), 400-403, 2011
Neuroimaging in amyotrophic lateral sclerosis
MR Turner, F Agosta, P Bede, V Govind, D Lulé, E Verstraete
Biomarkers in medicine 6 (3), 319-337, 2012
The system can't perform the operation now. Try again later.
Articles 1–20